Zhou, C. and Liu, S. 2022. Evaluation of the efficacy of MST-312, as a telomerase inhibitor, in the treatment of patients with multiple myeloma after stem cell transplantation. Cellular and Molecular Biology. 67, 4 (Jan. 2022), 115–120. DOI:https://doi.org/10.14715/cmb/2021.67.4.13.